Why try to beat 'em if you can just buy 'em? That's the approach that Questcor Pharmaceuticals (NASDAQ: QCOR ) is taking. The biotech announced today that it has acquired rights to develop Syncathen and�Synacthen Depot in the U.S. from�Novartis (NYSE: NVS ) . Questcor is paying $60 million up front and at least $75 million over the next few years, plus potential milestone payments. Shares were up nearly 25% in early trading.
What it means
Questcor appears to be playing both defense and offense with this move. On the defensive front, buying rights to Synacthen makes a lot of sense. Synacthen is a synthetic version of adrenocorticotropic hormone, or ACTH, which is the active ingredient in Acthar.
There's at least one big difference between Acthar and Synacthen, though. Questcor charges $28,000 per vial for Acthar. Synacthen Depot sells for around 3% of the cost of Acthar. You read that right -- Acthar costs 30 times more than the its synthetic rival.
5 Best Computer Hardware Stocks To Own Right Now: GNC Acquisition Holdings Inc. (GNC)
GNC Holdings, Inc. operates as a specialty retailer of health and wellness products. It operates through three segments: Retail, Franchise, and Manufacturing/Wholesale. The company�s products include vitamins, minerals, and herbal supplement products, as well as sports nutrition products, diet products, and other wellness products. It also manufactures its branded products for various third parties. The company sells its products under GNC proprietary brands, including Mega Men, Ultra Mega, Total Lean, Pro Performance, and Pro Performance AMP, as well as under third-party brands. As of March 31, 2013, it had approximately 8,200 locations, including 6,200 retail locations in the United States; and franchise operations in 55 countries. The company sells its products through company-owned domestic retail stores, domestic and international franchise activities, third-party contract manufacturing, e-commerce, and corporate partnerships. It also offers its products at GNC.com, LuckyVitamin.com, and drugstore.com. GNC Holdings, Inc. was founded in 1935 and is headquartered in Pittsburgh, Pennsylvania.
Advisors' Opinion:- [By Adam Haigh]
Asia�� benchmark stock index headed for the first monthly loss since August as GrainCorp Ltd. (GNC) plunged by a record after the Australian government rejected a takeover bid by a foreign rival.
Best Defensive Companies To Invest In Right Now: Becton Dickinson and Company(BDX)
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company?s BD Medical segment produces medical devices that are used in various healthcare settings. This segment?s products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes, pen needles, and other drugs to treat diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Diagnostics segment provides products for the safe collection and transport of diagnostics specimens, as well as instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment?s products consist of integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; and plated media. The company?s BD Biosciences segment produces research and clinical tools that facilitate the study of cells and their components. This segment?s products comprise fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. It markets its products through independent distribution channels and independent sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Advisors' Opinion:- [By Paul Vigna]
Becton Dickinson (BDX) & Co. said its fourth-quarter profit more than doubled on strong sales in segments such as diabetic systems and continued strength in emerging markets. Shares were up 2% to $130 premarket.
- [By Geoff Gannon]
Someone who reads my articles sent me this question: My��uestion has to do with the type of investments you tend to put your energy toward. Evaluating a net-net is a whole lot different than evaluating a company that has a competitive advantage and trades at much higher multiples. To me, the net-net evaluation process is a whole lot more straightforward, as there are fewer intangibles (if any) and less prediction about the future involved. I don't have to worry about whether GTSI (GTSI) has any competitive advantage ��I know it doesn't. Then again, I look at a company like Becton Dickenson (BDX) and I see a highly predictable company with a decent moat selling at a reasonable price. I can look at BDX and figure I might earn 10-15% annually over a long time frame. That's really different from thinking about investing in a net-net where I can see how it's 30-50% undervalued now, but it's not something I'm going to hold onto for decades. It's more of a matter of waiting for that one-time "pop" that will happen sometime in the next 1-5 years. How do you decide where to put your energy?
Best Defensive Companies To Invest In Right Now: Koninklijke Ahold NV (AHONY)
Koninklijke Ahold N.V. (Ahold), incorporated on April 29, 1920, is engaged in the operation of retail food stores in the United States and Europe through subsidiaries and joint ventures. Ahold�� retail operations are presented in four segments: Stop & Shop/Giant-Landover, Giant-Carlisle, Albert Heijn and Albert/Hypernova. During the fiscal year ended January 3, 2010 (fiscal 2009), it operated 2,909 stores. On February 8, 2010, Ahold�� Giant-Carlisle acquired 25 stores from Ukrop�� Super Markets.
Franchisees operated 783 of the Albert Heijn, Etos and Gall & Gall stores, 463 of which were either owned by the franchisees or leased independently from Ahold. Of the 2,446 stores, 20% were company-owned and 80% were leased. Ahold�� stores range in size from 20 to over 10,000 square meters. Albert Heijn is a food retailer in the Netherlands. Etos is a health and beauty retailer in the Netherlands. Gall & Gall is a wine and liquor specialist in the Netherlands. Stop & Shop is a supermarket brand, operating in six states in the northeast United States. Giant-Landover is a supermarket brand, operating in four states in the mid-Atlantic United States. Peapod is an online grocery delivery service working in partnership with Stop & Shop and Giant-Landover. It also serves the metropolitan areas of Chicago, Illinois; Milwaukee and Madison, Wisconsin, and the northern areas of Indiana.
Advisors' Opinion:- [By Rich Duprey]
As mentioned, Kroger is still swallowing Harris Teeter and has said it needs time to make more acquisitions. Royal Ahold (NASDAQOTH: AHONY ) is also said to be leery about doing large acquisitions these days, while Cerberus recently finished acquiring the Albertsons and Acme chains from SUPERVALU (NYSE: SVU ) �for $3.3 billion.
Best Defensive Companies To Invest In Right Now: Tenaris S.A.(TS)
Tenaris S.A., through its subsidiaries, engages in the manufacture and sale of steel pipe products. The company produces and sells both seamless and welded steel tubular products and related services for the oil and gas industry, particularly oil country tubular goods used in drilling operations, and certain other industrial applications with a production process that consists in the transformation of steel into tubular products. It also offers welded steel pipe products primarily used in the construction of major pipeline projects for the transportation of gas and fluids. In addition, the company provides sucker rods, casing and tubing, drill pipes, thermal tubulars, coiled tubing, premium connections, pipe accessories, welded steel pipes for electric conduits, industrial equipment, and raw materials. Further, it involves in the ownership and licensing of steel technology, as well as in the financial sector. The company serves oil and gas companies, car manufacturers, ref ineries, and petrochemical and gas-processing plants, as well as engineering companies engaged in constructing oil and gas gathering, transportation, and processing facilities. It operates in North America, South America, Europe, the Middle East, Africa, the Far East, and Oceania. The company is headquartered in Luxembourg. Tenaris S.A. is a subsidiary of San Faustin N.V.
Advisors' Opinion:- [By ovenerio]
The company has a current ROE of 11.72% which is higher than the industry median. In general, analysts consider ROE ratios in the 15-20% range as representing attractive levels for investment. So for investors looking those levels or more, Halliburton (HAL) and Tenaris (TS) could be the option. It is very important to understand this metric before investing, and it is important to look at the trend in ROE over time.
- [By GURUFOCUS]
Maverick appeared to be one of the few bargains still available in the oils service and equipment sector in 2005. Shareholders were rewarded a year later when the company was acquired by Tenaris (TS) at a price of 65 dollars a share in June of 2006.
Best Defensive Companies To Invest In Right Now: IMAX Corp (IMAX)
IMAX Corporation, incorporated on January 1, 2002, together with its wholly owned subsidiaries, is an entertainment technology companies, specializing in motion picture technologies and presentations. The Company�� customers who purchase lease or otherwise acquire the IMAX theatre systems are theatre exhibitors, which operate commercial theatres, museums, science centers, and destination entertainment sites. IMAX theatre systems combine the Company�� digital re-mastering movie conversion technology (IMAX DMR), projectors with equipment and automated theatre control systems, sound system components, screens, theatre geometry, and theatre acoustics.
The Company�� principal business is the design, manufacture and delivery of theater systems (IMAX theater systems). The Company�� customers who purchase, lease or otherwise acquire the IMAX theater systems through joint revenue sharing arrangements are theater exhibitors that operate commercial theaters (particularly multiplexes), museums, science centers, or destination entertainment sites. The Company does not own IMAX theaters, but licenses the use of its trademarks along with the sale, lease or contribution of the IMAX theater system.
IMAX Systems, Theater System Maintenance and Joint Revenue Sharing Arrangements
The Company provides IMAX theater systems to customers on a sales or long-term lease basis with an initial 10-year term. These agreements consist of initial fees and ongoing fees (which can include a fixed minimum amount per annum and contingent fees in excess of the minimum payments) and maintenance and extended warranty fees. The initial fees vary depending on the system configuration and location of the theater and generally are paid to the Company in installments between the time of system signing and the time of system installation. Ongoing fees are paid over the term of the contract, commencing after the theater system has been installed and are generally equal to the greater of a fixed minimu! m amount per annum or a percentage of boxoffice receipts. The Company also provides IMAX theater systems to customers under joint revenue sharing arrangements, pursuant to which the Company provides the IMAX theater system in return for a portion of the customer�� IMAX box-office receipts, and in some cases concession revenues and/or a small upfront or initial payment. As at December 31, 2012, the Company had 316 theaters in operation under joint revenue sharing arrangements.
Production and Digital Re-Mastering (IMAX DMR)
The Company�� technology digitally re-masters Hollywood films into IMAX digital cinema package format or 15/70-format film. IMAX DMR digitally enhances the image resolution of motion picture films for projection on IMAX screens while maintaining or enhancing the visual clarity and sound quality to levels for which The IMAX Experience is known. This technology enabled the IMAX theater network to release Hollywood films simultaneously with domestic release. In a typical IMAX DMR film arrangement, the Company will receive a percentage of net box-office receipts of any commercial films released in the IMAX network, which is generally 10-15%, from a film studio for the conversion of the film to the IMAX DMR format and access to its distribution platform. During the year ended December 31, 2012, 35 films converted through the IMAX DMR process were released to theaters within the IMAX network. As of December 31, 2012, the Company released 23 IMAX DMR titles to theaters within the IMAX network. During 2012, five local language IMAX DMR films were released, including one French film, Houba! On the Trail of the Marsupilami: The IMAX Experience and four Chinese IMAX DMR titles: Tai Chi 0: An IMAX 3D Experience, Tai Chi Hero: An IMAX 3D Experience, Back to 1942: The IMAX Experience and CZ12: The IMAX Experience.
Film Distribution and Post-Production
The Company is also a distributor of large-format films, primarily catering to its institution! al theate! r partners. The Company generally distributes films, which it produces or for which it has acquired distribution rights from independent producers. The Company generally receives a percentage of the theater box-office receipts as a distribution fee. Films produced by the Company are typically financed through third parties, whereby the Company will generally receive a film production fee in exchange for producing the film and a distribution fee for distributing the film. The Company utilizes third-party funding for the majority of original films it produces and distributes. In 2012, the Company, along with Warner Bros. Pictures (WB) and MacGillivray Freeman Films (MFF) released an original title, To the Artic 3D: An IMAX 3D Experience.
The Company derives a small portion of its revenues from other sources. As of December 31, 2012, the Company had four owned and operated theaters. In addition, the Company has a commercial arrangement with one theater resulting in the sharing of profits and losses and provides management services to two theaters. The Company also rents its two dimensional (2D) and three dimensional (3D) large-format film and digital cameras to third party production companies. The Company maintains cameras and other film equipment and also offers production advice and technical assistance to both documentary and Hollywood filmmakers. Additionally, the Company generates revenues from the sale of after-market parts and 3D glasses. As of December 31, 2012, approximately 54.2% of IMAX systems in operation were located in the United States and Canada. As at December 31, 2012, approximately 45.8% of IMAX systems in operation were located within international markets (other than the United States and Canada).
Advisors' Opinion:- [By Rick Munarriz]
One wouldn't expect exhibitors to rally around a movie that is available at home for no additional cost to Netflix's more than 50 million streaming accounts. The theatrical release next August is limited to IMAX (NYSE: IMAX ) and its more than 800 supersized screens worldwide. It won't be the last time that we see this happen, as Netflix and IMAX are teaming up for "several major films" that will be financially backed by Netflix.
- [By Dan Caplinger]
The main rival that RealD faces is IMAX (NYSE: IMAX ) , and the biggest challenge IMAX poses for RealD is that IMAX and its huge-screen theaters give viewers an impressive experience even with 2-D films. That flexibility has been a key component driving IMAX's growth, with a global footprint extending to hundreds of theaters in more than 50 countries worldwide. RealD has tried to match that with its precision white-screen technology, but RealD can't make theater-operators install the huge screens to match up to IMAX.
- [By Rich Smith]
IMAX's (NYSE: IMAX ) march to world domination continues.
After announcing expansions of its theater network in first Russia, then Mexico, then Indonesia earlier this year, the theater-tech company announced Monday that it is partnering with CJ CGV Holdings to add 35 new IMAX theaters in China and South Korea. Five of these new theater locations, the Korean ones, had been previously optioned, but are now confirmed. The 30 Chinese locations are officially "new" news.
- [By Chris Katje]
Two other companies should be watched in the "Jurassic Park" mania. In 2013, "Jurassic Park" was re-released in theaters to celebrate the film's 20th anniversary. IMAX theaters (IMAX) showed the movie on their huge screens and saw big results. In the film's opening weekend, IMAX saw box office revenue of $6 million. This represented 32% of total domestic opening weekend box office and marked the highest market share of a wide release movie for IMAX. If IMAX can score the rights to the fourth movie, it should add to an already potential blockbuster and record breaking 2015 summer.
Best Defensive Companies To Invest In Right Now: Central Garden & Pet Company (CENTA)
Central Garden & Pet Company produces and sells various products for the pet, and lawn and garden supplies markets in the United States. The company operates in two segments, Pet, and Lawn and Garden. The Pet segment supplies products for dogs and cats comprising edible bones, edible and non-edible chews, dog and cat food and treats, toys, pet carriers, grooming supplies, and other accessories; and food, cages and habitats, toys, chews, and related accessories for birds, small animals, and specialty pets. It also offers animal and household health, and insect control products; aquariums, furniture and lighting fixtures, pumps, filters, water conditioners, food and supplements, and information and knowledge resources for fish, reptiles, and other aquarium-based pets; and products for horses and livestock. This segment sells its products to independent pet distributors, retail chains, grocery stores, mass merchants, and bookstores under various brand names, which include Ada ms, Aqueon, Avoderm, BioSpot, Farnam, Four Paws, Kaytee, Nylabone, Pinnacle, TFH, Zilla, Altosid, Comfort Zone, Coralife, Interpet, Kent Marine, Oceanic Systems, Pet Select, Pre-Strike, Super Pet, and Zodiac. The Lawn and Garden segment provides grass seeds; wild bird feed, bird feeders, bird houses, and other birding accessories; weed, grass, ant and other herbicide, insecticide, and pesticide products; and decorative outdoor lifestyle and lighting products, such as comprising potteries, trellises and other wood products, and holiday lighting products. This segment sells its products to retail chains, independent garden distributors, grocery stores, nurseries, and garden supply retailers under the AMDRO, GKI/Bethlehem Lighting, Ironite, Pennington, Sevin, Grant�s, Lilly Miller, Matthews Four Seasons, New England Pottery, Norcal Pottery, Over-N-Out, Smart Seed, and The Rebels brand names. The Company was founded in 1955 and is based in Walnut Creek, California.
Advisors' Opinion:- [By Sean Williams]
Green paw
The month of May has been one to forget for shareholders of Central Garden & Pet (NASDAQ: CENT ) (NASDAQ: CENTA ) . The maker of pet products as well as seeds and herbicides for lawn care tumbled after it missed Wall Street's earnings estimates for a second straight quarter. The biggest downside pressure came from its lawn care segment, which saw expenses rise as fertilizer margins fell. However, now could be the time to consider jumping on board this interesting pet/lawn care hybrid company, as it has the potential to unlock shareholder value in a number of ways.
Best Defensive Companies To Invest In Right Now: International Game Technology (IGT)
International Game Technology (IGT) designs, manufactures, and markets electronic gaming equipment and systems worldwide. The company offers casino-style slot machines that determine the game play outcome at the machine; wide area progressive jackpot systems with linked machines across various casinos; central determination system machines connected to a central server that determines the game outcome, encompassing video lottery terminals used primarily in government-sponsored applications and electronic or video bingo machines; and amusement with prize games. Its systems products include applications for casino management, customer relationship marketing (CRM), and server-based games and player management. IGT?s casino management solutions comprise integrated modules for machine accounting, patron management, cage and table accounting, ticket-in/ticket-out, bonusing (jackpots and promotions), and table game automation. The company?s CRM solutions feature integrated market ing and business intelligence modules that provide analytical, predictive, and management tools for maximizing casino operational effectiveness; and server-based solutions enable game delivery to slot machines, computers, mobile phones, tablets, and other networked devices. Its gaming markets comprise the United States, Canada, Europe, the Middle East, Africa, Mexico and South/Central America, Asia, Australia, New Zealand, the Pacific, and the United Kingdom. The company was founded in 1980 and is headquartered in Reno, Nevada.
Advisors' Opinion:- [By John Divine]
Lastly, slot machine maker International Game Technology (NYSE: IGT ) slumped 7.3%, due largely to negative analyst sentiment. Unlike AMD and Microsoft, IGT doesn't report quarterly results until next Tuesday, so the comments today were sure to attract the attention of some uneasy investors before official numbers come out. A Janney Capital Markets analyst said that the stock's been driven up to a point where it no longer offers newcomers an attractive entry point. On top of that, IGT is set to start losing market share, will see higher costs, and will be able to buy back less stock in the future, according to the report.�
- [By Stock Maelstrom]
International Games Technology (IGT) is the leading company in this industry. Its market capitalization of $4.6 billion is twice that of Bally Tech. International's fiscal 2013 ends September 30th, and by all indications it will be an excellent year, both in terms of comparisons with 2012 and historical references. For instance in its second quarter, the company's $600 million in revenue were up about 12% from the second quarter of fiscal 2012, and profits of $95 million, or $0.36 per share, were up 33% from the year ago. The stock market has rewarded three consecutive quarters of strong profit comparisons, bidding up shares by over 50% since September, 2012. The company also recently raised its dividend by 12.5%, paying a current yield of 1.8%. But most analysts see profit growth flattening off in fiscal 2014. I wonder if much of International Games' growth is actually behind it. For that reason, I do not like this otherwise impressive company as much as Bally Tech over the next two to three year period.
No comments:
Post a Comment